GENE ONLINE|News &
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
CRISPR-Cas13 is an RNA editing technique that can manipulate gene expression at the RNA level without modifying the genome. However, the delivery of RNA editors is perhaps the biggest barrier to the widespread adoption of this approach.
The therapeutic delivery of Cas13-based RNA editing systems remains challenging, in part because the size of Cas13-based RNA editors developed so far exceeds the packaging capacity of adeno-associated virus (AAV), the most widely used viral vector for gene delivery.
The therapeutic delivery of Cas13-based RNA editing systems remains challenging, in part because the size of Cas13-based RNA editors developed so far exceeds the packaging capacity of adeno-associated virus (AAV), the most widely used viral vector for gene delivery.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
